Gynecare says gets FDA okay for VersaPoint . Gynecare Inc said on Monday the Food and Drug Administration had cleared for marketing the company ' s VersaPoint system for hysteroscopic fibroid removal , a minimally invasive alternative to hysterectomy . The VersaPoint system is designed to reduce the risks of traditional surgical fibroid removal procedures , the company said . The system enables gynecologists to vaporize , cut or desiccate tissue . Uterine fibroids are the leading cause of hysterectomy , the surgical removal of the uterus , in the United States , the company said . - - New York Newsdesk 212 - 859 - 1610 
